ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $3,622,000 | -22.5% | 568,527 | -2.0% | 0.02% | -25.0% |
| Q1 2014 | $4,675,000 | -29.1% | 580,044 | -40.0% | 0.02% | -33.3% |
| Q4 2013 | $6,595,000 | -38.4% | 966,984 | +66.3% | 0.03% | -43.4% |
| Q3 2013 | $10,698,000 | +18.1% | 581,413 | +12.3% | 0.05% | +10.4% |
| Q2 2013 | $9,057,000 | – | 517,822 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |